We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Eli Lilly’s rheumatoid arthritis treatment Olumiant (baricitinib) reduced mortality in COVID-19 patients by 71 percent in a small clinical trial led by Sweden’s Karolinska Institutet. Read More
Moderna announced this week that its coronavirus vaccine, mRNA-1273, appears to not only be more effective than Pfizer’s candidate but has significantly less stringent temperature requirements as well, likely making distribution and storage of the vaccine an easier, less daunting task. Read More
Inovio has launched the phase 2 portion of its phase 2/3 clinical trial evaluating INO-4800, a potential coronavirus vaccine funded by the Department of Defense (DoD). Read More
Hacker groups in Russia and North Korea have continue to wage cyberattacks against companies working on COVID-19 vaccines and treatments, Microsoft warned Monday, calling on governments to take action against them. Read More
A new survey shows one in five cancer patients are far less likely to participate in future clinical trials due to fear of COVID-19 exposure, raising the question of whether enrollment levels that have dropped precipitously since the beginning of the pandemic are likely to recover after the virus is controlled. Read More